Non-Accredited Education
Understanding Collagen Dressings and their Benefit in Wound Care Complimentary Archived Webcast
Non-Accredited
Issue
- Issue:3
Anacapa Technologies, Inc. – Booth 723
Anasept™ Skin & Wound Antiseptic is a non-cytotoxic, extremely fast-acting, antimicrobial skin and wound cleanser with broad-spectrum, bactericidal (including the antibiotic resistant strains MRSA & VRE, and Acinetobacter baumanii) , fungicidal and virucidal properties. Anasept is available in both spray and pour bottle applicators.
- Issue:3
The development of an infected acute wound porcine model
D. Boone, MD, E. Braitman, MD, J. Afthinos, MD, C. Gendics, RN, E. Sordillo, MD, PhD, G. Todd, MD, J. Lantis, MD - Issue:3
Disclosure: Dr. Granick was a medical consultant for Smith & Nephew Inc (Largo, Fla)
- Issue:3
With longer survival rates of patients with diabetes the incidence of Charcot arthropathy has been noted to be increasing in occurrence within the last several years.1 Charcot arthropathy is a noninfective progressive process that was first reported by Jean-Martin Charcot in 1868.2 It was originally described in neuropathic patients with tertiary syphilis, although it is now most commonly associated with diabetes mellitus.
- Issue:3
Diabetes and Lesions of the Foot
Diabetes is a common condition in the United States, affecting more than 10 million adults.1 Wounds of the foot are the most common reason for hospitalization in patients with diabetes;2,3 it is estimated that 15% to 20% of patients with diabetes will develop an ulcer on their foot at some point,4 and for many of these cases, the most appropriate treatment results in some form of surgery.
- Issue:3
NPWT Therapy More Effective Than Alternate Treatment
Kinetic Concepts Inc (San Antonio, Tex) announced the final results of a randomized controlled clinical trial for the efficacy of the company’s V.A.C.® System negative pressure wound therapy compared to advanced moist wound therapy (AMWT) in treating diabetic foot ulcers.
- Issue:3
New Educational Campaign Launched for Apligraf®
Organogenesis Inc (Canton, Mass) is launching a direct-to-consumer educational campaign for its living cell-based therapy, Apligraf®.
Designed to treat venous leg ulcers and diabetic foot ulcers, Apligraf contains 2 layers of living cells that integrate into the wound and produce more than 40 substances, such as cytokines, that are important to healing.
Press Release
ConvaTec and Boehringer Technologies Announce License Agreement
ConvaTec Acquires Exclusive Worldwide Rights for a Negative Pressure Wound Therapy System
SKILLMAN, NJ (December 18, 2008) — ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, announced today it has signed a long-term global exclusive license agreement with Boehringer Technologies to market and distribute Boehringer’s Engenex® Negative Pressure Wound Therapy (NPWT) System incorporating Bio-Dome™ Interface Technology.
WOUNDS News Wire
- Friday, December 5, 2008 - 15:08
- Wednesday, October 22, 2008 - 15:28
- Wednesday, October 22, 2008 - 15:25
CME Showcase
"Diabetic Peripheral Neuropathy"
Upcoming Accredited Webcast Release Date: December 22, 2008 Expiration Date: December 22, 2009 This activity is supported by an educational grant from PamLabs. To register for this Webcast, visit www.naccme.com/program/n-558/ |
"Current Concepts In Healing Chronic Diabetic Foot Ulcerations"
Upcoming Live Accredited Webcast with Q&A Noon to 1 p.m. EDT January 20, 2009 Rebroadcasts 7:30-8:30 p.m. EDT 3-4 p.m. EDT This activity is supported by an educational grant from Advanced Biohealing. To register for this Webcast, visit www.naccme.com/program/n-550/ |
| MRSA And Diabetic Foot Wounds: Where Do We Go From Here? Accredited Webcast Archive Version available now. This activity is supported by an educational grant from Pfizer. This activity is sponsored by the North American Center For Continuing Medical Education (NACCME). |
|
PERIPHERAL ARTERIAL DISEASE (PAD) AND CRITICAL LIMB ISCHEMIA (CLI): Managing Vascular and Wound Healing Challenges with Current and Emerging Technologies Maintenance Debridement: A New Look at Science and Art Accredited Webcast with Q&A: November 17, 2008 at 3:00pm EST This activity is supported by an educational grant from HealthPoint Ltd. |
REVIEW OUR OTHER
WOUND CARE BRANDS
Check out our other resources for healthcare professionals of all specialties.
